Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

News

DGAP-News: 4basebio AG: 4basebio AG Reports positive Financial Results for Fiscal Year 2019 - Financial Guidance Met
DGAP-News: 4basebio AG: 4basebio AG Reports positive Financial Results for Fiscal Year 2019 - Financial Guidance Met
DGAP-News: 4basebio AG: 4basebio AG Reports positive Financial Results for Fiscal Year 2019 - Financial Guidance Met
DGAP-Adhoc: BB Biotech AG publishes its interim report
DGAP-Adhoc: BB Biotech AG publishes its interim report
DGAP-Adhoc: BB Biotech AG publishes its interim report
DGAP-News: BB BIOTECH AG: Resilient biotech sector despite widespread market turmoil
DGAP-News: BB BIOTECH AG: Resilient biotech sector despite widespread market turmoil
DGAP-News: BB BIOTECH AG: Resilient biotech sector despite widespread market turmoil
DGAP-News: CPI PROPERTY GROUP - Positive Early Signs Regarding the Impact of COVID-19
DGAP-News: CPI PROPERTY GROUP - Positive Early Signs Regarding the Impact of COVID-19
DGAP-News: CPI PROPERTY GROUP - Positive Early Signs Regarding the Impact of COVID-19
DGAP-Adhoc: Vapiano SE: Extension of the appointment of Vanessa Hall as CEO, resignation of Johann Stohner as CTO
DGAP-Adhoc: Vapiano SE: Extension of the appointment of Vanessa Hall as CEO, resignation of Johann Stohner as CTO
DGAP-Adhoc: Vapiano SE: Extension of the appointment of Vanessa Hall as CEO, resignation of Johann Stohner as CTO
DGAP-Adhoc: Uniper expects very strong first quarter for financial year 2020 - earnings outlook for the full financial year 2020 confirmed
DGAP-Adhoc: Uniper expects very strong first quarter for financial year 2020 - earnings outlook for the full financial year 2020 confirmed
DGAP-Adhoc: Uniper expects very strong first quarter for financial year 2020 - earnings outlook for the full financial year 2020 confirmed
DGAP-News: Bundesliga prepared to continue current season without spectators from May 2020 onwards: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24094/225px-Borussia_Dortmund_logo.svg.png
DGAP-News: Bundesliga prepared to continue current season without spectators from May 2020 onwards
DGAP-News: Bundesliga prepared to continue current season without spectators from May 2020 onwards
DGAP-Adhoc: MOLOGEN AG: Revocation of admission to Prime Standard
DGAP-Adhoc: MOLOGEN AG: Revocation of admission to Prime Standard
DGAP-Adhoc: MOLOGEN AG: Revocation of admission to Prime Standard
PAO Severstal: Recommended Q1 2020 Dividend, the AGM form and agenda
PAO Severstal: Recommended Q1 2020 Dividend, the AGM form and agenda
PAO Severstal: Recommended Q1 2020 Dividend, the AGM form and agenda
SWEF: TR-1 Notification of Major Interest in Shares
SWEF: TR-1 Notification of Major Interest in Shares
SWEF: TR-1 Notification of Major Interest in Shares
DGAP-Adhoc: Deutsche Lufthansa AG: Lufthansa Group publishes preliminary results for the first quarter and provides outlook on liquidity development: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/23600/375px-Lufthansa-Logo.svg.png
DGAP-Adhoc: Deutsche Lufthansa AG: Lufthansa Group publishes preliminary results for the first quarter and provides outlook on liquidity development
DGAP-Adhoc: Deutsche Lufthansa AG: Lufthansa Group publishes preliminary results for the first quarter and provides outlook on liquidity development
HMS Group: Result of Meeting
HMS Group: Result of Meeting
HMS Group: Result of Meeting
Form 8.3 - The Vanguard Group, Inc.: Aon plc
Form 8.3 - The Vanguard Group, Inc.: Aon plc
Form 8.3 - The Vanguard Group, Inc.: Aon plc
Form 8.3 - The Vanguard Group, Inc.: Allergan plc
Form 8.3 - The Vanguard Group, Inc.: Allergan plc
Form 8.3 - The Vanguard Group, Inc.: Allergan plc
Form 8.3 - The Vanguard Group, Inc.: AbbVie plc
Form 8.3 - The Vanguard Group, Inc.: AbbVie plc
Form 8.3 - The Vanguard Group, Inc.: AbbVie plc
Rights and Issues Investment Trust PLC: Net Asset Value(s)
Rights and Issues Investment Trust PLC: Net Asset Value(s)
Rights and Issues Investment Trust PLC: Net Asset Value(s)
DGAP-Adhoc: Wacker Neuson SE: Executive Board and Supervisory Board propose suspension of the dividend payment; virtual Annual General Meeting planned for June 30, 2020: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24131/375px-Wacker_Neuson_Group_Logo.png
DGAP-Adhoc: Wacker Neuson SE: Executive Board and Supervisory Board propose suspension of the dividend payment; virtual Annual General Meeting planned for June 30, 2020
DGAP-Adhoc: Wacker Neuson SE: Executive Board and Supervisory Board propose suspension of the dividend payment; virtual Annual General Meeting planned for June 30, 2020
Chelverton UK Dividend Trust plc: Net Asset Value(s)
Chelverton UK Dividend Trust plc: Net Asset Value(s)
Chelverton UK Dividend Trust plc: Net Asset Value(s)
Form 8.3 - The Vanguard Group, Inc.: Willis Towers Watson plc
Form 8.3 - The Vanguard Group, Inc.: Willis Towers Watson plc
Form 8.3 - The Vanguard Group, Inc.: Willis Towers Watson plc
Form 8.3 - The Vanguard Group, Inc.: Pollen Street Secured Lending plc
Form 8.3 - The Vanguard Group, Inc.: Pollen Street Secured Lending plc
Form 8.3 - The Vanguard Group, Inc.: Pollen Street Secured Lending plc
DGAP-News: Coreo releases consolidated figures (IFRS) for 2019
DGAP-News: Coreo releases consolidated figures (IFRS) for 2019
DGAP-News: Coreo releases consolidated figures (IFRS) for 2019
DGAP-News: ADO Properties S.A.: ADO Properties' rating adjusted by S&P
DGAP-News: ADO Properties S.A.: ADO Properties' rating adjusted by S&P
DGAP-News: ADO Properties S.A.: ADO Properties' rating adjusted by S&P
DGAP-News: aap receives approval from ethics commissions for human clinical study for innovative antibacterial silver coating technology; all regulatory requirements for starting study in Germany fulfilled
DGAP-News: aap receives approval from ethics commissions for human clinical study for innovative antibacterial silver coating technology; all regulatory requirements for starting study in Germany fulfilled
DGAP-News: aap receives approval from ethics commissions for human clinical study for innovative antibacterial silver coating technology; all regulatory requirements for starting study in Germany fulfilled
Hardman & Co Research: Q&A with Mike Foster on Surface Transforms (SCE): High visibility for 2021 onwards; equity raise
Hardman & Co Research: Q&A with Mike Foster on Surface Transforms (SCE): High visibility for 2021 onwards; equity raise
Hardman & Co Research: Q&A with Mike Foster on Surface Transforms (SCE): High visibility for 2021 onwards; equity raise
DGAP-News: ElringKlinger hosts annual general meeting virtually: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24101/330px-ElringKlinger-Logo.svg.png
DGAP-News: ElringKlinger hosts annual general meeting virtually
DGAP-News: ElringKlinger hosts annual general meeting virtually